Guang Cao

1.0k total citations · 1 hit paper
51 papers, 713 citations indexed

About

Guang Cao is a scholar working on Hepatology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Guang Cao has authored 51 papers receiving a total of 713 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hepatology, 18 papers in Surgery and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Guang Cao's work include Hepatocellular Carcinoma Treatment and Prognosis (25 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (14 papers) and Gastric Cancer Management and Outcomes (5 papers). Guang Cao is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (25 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (14 papers) and Gastric Cancer Management and Outcomes (5 papers). Guang Cao collaborates with scholars based in China, Ethiopia and United States. Guang Cao's co-authors include Xu Zhu, Renjie Yang, Hui Chen, Xiaodong Wang, Haifeng Xu, Wilfred Hing Sang Wong, Baocai Xing, Quan Bao, Jian Ma and Quanhui Peng and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Guang Cao

48 papers receiving 709 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sorafenib Plus Hepatic Arterial Infusion Chemotherapy versus Sorafenib for Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis: A Randomized Trial

2022 101 citations Xu Zhu, Guang Cao et al. Radiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Guang Cao China	15	301	168	145	134	118	51	713
Jinzhen Cai China	13	75 0.2×	96 0.6×	41 0.3×	140 1.0×	50 0.4×	38	412
Katsumi Eguchi Japan	15	28 0.1×	83 0.5×	41 0.3×	172 1.3×	68 0.6×	37	641
Namita Roy‐Chowdhury United States	20	470 1.6×	504 3.0×	53 0.4×	448 3.3×	151 1.3×	34	1.1k
Xueyang Li China	15	37 0.1×	378 2.3×	34 0.2×	354 2.6×	44 0.4×	45	824
Min Deng China	13	50 0.2×	80 0.5×	19 0.1×	129 1.0×	46 0.4×	49	403
Hiroshi Hisatsune Japan	12	139 0.5×	385 2.3×	42 0.3×	518 3.9×	189 1.6×	20	982
Peter Laws Australia	9	117 0.4×	256 1.5×	24 0.2×	150 1.1×	90 0.8×	20	553
Hongyi Zhang China	14	30 0.1×	146 0.9×	25 0.2×	174 1.3×	89 0.8×	53	573
Erna Sziksz Hungary	14	41 0.1×	118 0.7×	43 0.3×	207 1.5×	65 0.6×	29	665
Yoshihiro Morimoto Japan	16	71 0.2×	164 1.0×	54 0.4×	315 2.4×	96 0.8×	68	870

Countries citing papers authored by Guang Cao

Since Specialization

Citations

This map shows the geographic impact of Guang Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guang Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guang Cao more than expected).

Fields of papers citing papers by Guang Cao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guang Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guang Cao. The network helps show where Guang Cao may publish in the future.

Co-authorship network of co-authors of Guang Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Guang Cao. A scholar is included among the top collaborators of Guang Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guang Cao. Guang Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Pengjun, et al.. (2024). Extrachromosomal circular DNA (eccDNA) characteristics in the bile and plasma of advanced perihilar cholangiocarcinoma patients and the construction of an eccDNA-related gene prognosis model. Frontiers in Cell and Developmental Biology. 12. 1379435–1379435. 3 indexed citations

Li, Jie, Hua Fan, Guang Cao, et al.. (2024). NLCECA score: a serum inflammatory-tumor biomarker score to predict survival of advanced perihilar cholangiocarcinoma after hepatic arterial infusion chemotherapy. Scientific Reports. 14(1). 4466–4466. 3 indexed citations

Ma, Jian, et al.. (2024). High-concentrate diet supplemented with hydrolysable tannin improves the slaughter performance, intestinal antioxidant ability and barrier function of fattening lambs. Frontiers in Veterinary Science. 11. 1464314–1464314.

Cao, Guang, et al.. (2023). Zinc oxide/Polydopamine@PNIPAm core-shell phase change nanocomposite for samrt NIR-responsive drug delivery systems. Journal of Drug Delivery Science and Technology. 84. 104522–104522. 5 indexed citations

Zhang, Xin, Xiaodong Wang, Hui Chen, et al.. (2023). Efficacy and safety of irinotecan-eluting HepaSphere transarterial chemoembolization combined with hepatic arterial infusion chemotherapy for unresectable colorectal liver metastases.. Journal of Clinical Oncology. 41(16_suppl). 3585–3585. 1 indexed citations

Zhang, Xin, Xiaodong Wang, Guang Cao, et al.. (2023). A Novel Nomogram for Predicting the Overall Survival in Patients with Unresectable HCC after TACE plus Hepatic Arterial Infusion Chemotherapy. Translational Oncology. 34. 101705–101705. 8 indexed citations

Cao, Guang, et al.. (2023). HAIC as a potential therapy for esophageal cancer patients with liver metastasis: a retrospective cohort study. Frontiers in Medicine. 10. 1143617–1143617. 1 indexed citations

Zhu, Xu, Guang Cao, Wenqing Li, et al.. (2022). Sorafenib Plus Hepatic Arterial Infusion Chemotherapy versus Sorafenib for Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis: A Randomized Trial. Radiology. 303(2). 455–464. 101 indexed citations breakdown →

Cao, Guang, Xiaodong Wang, Hui Chen, et al.. (2022). Hepatic arterial infusion chemotherapy plus regorafenib in advanced colorectal cancer: a real-world retrospective study. BMC Gastroenterology. 22(1). 328–328. 4 indexed citations

10.

Cui, Yong, Renjie Yang, Guang Cao, et al.. (2022). Signal enhancement ratio of CE-MRI: a potential biomarker of survival after hepatic arterial infusion chemotherapy in biliary tract cancers. Insights into Imaging. 13(1). 46–46. 1 indexed citations

11.

Zhu, Xu, Xin Zhang, Xiaodong Wang, et al.. (2021). Combination Therapy of Chemoembolization and Hepatic Arterial Infusion Chemotherapy in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis Compared with Chemoembolization Alone: A Propensity Score‐Matched Analysis. BioMed Research International. 2021(1). 6670367–6670367. 20 indexed citations

12.

Wang, X., Guang Cao, Liang Xu, et al.. (2020). 984P Sorafenib plus hepatic arterial infusion chemotherapy versus sorafenib alone for advanced hepatocellular carcinoma with major portal vein tumor thrombosis (Vp3/4): A randomized phase II trial. Annals of Oncology. 31. S689–S689. 1 indexed citations

13.

Cao, Guang, Liang Xu, Xu Zhu, et al.. (2020). Retrograde embolization technique of the right gastric artery during the implantation of port-catheter system for hepatic arterial infusion chemotherapy. SHILAP Revista de lepidopterología. 4(1). 27–31. 3 indexed citations

14.

Ma, Jian, Zhisheng Wang, Yu Xiong, et al.. (2020). Comparing the Bacterial Community in the Gastrointestinal Tracts Between Growth-Retarded and Normal Yaks on the Qinghai–Tibetan Plateau. Frontiers in Microbiology. 11. 600516–600516. 41 indexed citations

15.

Zhang, Xin, Di Wu, Xiaoting Li, et al.. (2020). Transarterial chemoembolization with hepatic arterial infusion chemotherapy plus S-1 for hepatocellular carcinoma. World Journal of Gastroenterology. 26(27). 3975–3988. 11 indexed citations

16.

Li, Weiliang, Xiaodong Wang, Guang Cao, et al.. (2019). circCCT3 Modulates Vascular Endothelial Growth Factor A and Wnt Signaling to Enhance Colorectal Cancer Metastasis Through Sponging miR-613. DNA and Cell Biology. 39(1). 118–125. 36 indexed citations

17.

Gao, Song, Hui Chen, Xiaodong Wang, et al.. (2018). Effect of primary tumor side on survival outcomes in metastatic colorectal cancer patients after hepatic arterial infusion chemotherapy. World Journal of Gastrointestinal Oncology. 10(11). 431–438. 4 indexed citations

18.

Maybody, Majid, Guang Cao, Xiao Wang, et al.. (2016). Lipiodol retention pattern assessed by cone beam computed tomography during conventional transarterial chemoembolization of hepatocellular carcinoma: accuracy and correlation with response. Cancer Imaging. 16(1). 32–32. 14 indexed citations

19.

Cao, Guang. (2012). Transcatheter arterial chemoembolization for gastrointestinal stromal tumors with liver metastases. World Journal of Gastroenterology. 18(42). 6134–6134. 21 indexed citations

20.

Guan, Sheng, Wei Zhao, Kang Zhou, et al.. (2006). Sequential hemodynamic changes in precancerous lesions of hepatocellular carcinoma: Experimental study with MR perfusion. Zhonghua fangshexian yixue zazhi. 40(3). 231–234. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact